Direct reflections from inside Switzerland Omics on genomics, infrastructure, product judgement, and the future of our field.
- AlphaGenome Atlas - what would validate it? — 2026-09-09
- Designing a patient-specific mRNA cancer vaccine — 2026-08-21
- Fine-tuning foundation models with biological priors — 2026-08-15
- Founders of Element Biosciences — 2026-06-09
- AI as a horizontal layer — 2026-05-20
- The anatomy of algorithm acquisitions — 2026-05-17
- How Roche turns science into healthcare infrastructure — 2026-05-16
- Quinary inference, the fifth layer of genomics — 2026-03-15
- When sequencing became infrastructure — 2026-03-14
- The real industry bottleneck after genome sequencing — 2026-02-15
- Founders of sequencing by expansion SBX — 2026-02-14
- Founders of dbNSFP — 2026-02-08
- Founders of Phred Phrap Consed — 2026-02-01
- Founders of HGMD — 2026-01-25
- Founders of ANNOVAR — 2026-01-18
- Founders of GRAIL — 2026-01-17
- The Illumina GRAIL acquisition and divestment case — 2026-01-11
- Founders of Illumina — 2026-01-04
- Why evidence availability needs a standard — 2025-12-15
- Open standards for a genomics ecosystem — 2025-11-27
- Quantifying variant evidence — 2025-09-19
- The new paradigm of causal genomic interpretation through Bayesian posterior inference — 2025-08-01
- Alignment with Sutton's bitter lesson — 2025-07-27
- Technical publications and brand discipline — 2025-06-15
- Quantifying variant classifications with probabilistic reasoning — 2025-05-21
- Keep the product message clear — 2025-05-10
